Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome– a single center experience by Sam Kant, Anshul Bhalla, Sami Alasfar, Nada Alachkar

Get full text

Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria by Mohammad Abuzeineh, Amtul Aala, Sami Alasfar, Nada Alachkar

Get full text

Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab by Nada Alachkar, Jing Li, Dany Matar, Vikas Vujjini, Sami Alasfar, Melissa Tracy, Jochen Reiser, Changli Wei

Get full text

Prospective Assessment of the Prevalence of Enter Hyperoxalosis in Kidney Transplant Candidates by Christina Mejia, MD, Anam Tariq, DO, MHS, Manal Alotaibi, MD, Laila Lakhani, MBBS, Wendy Greenspan, RN, Fizza Naqvi, MD, Sami Alasfar, MD, Daniel C. Brennan, MD

Get full text

Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy by Yousuf Kyeso, MD, Anshul Bhalla, MD, Alyssa P. Smith, BSc, Yaqi Jia, MPH, Safa Alakhdhair, MS, Stephanie C. Ogir, BA, Mohammad Abuzeineh, MD, Daniel C. Brennan, MD, Sami Alasfar, MD

Get full text

Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration by Laila Lakhani, MD, Sami Alasfar, MD, Anshul Bhalla, MD, Amtul Aala, MD, Avi Rosenberg, MD, Darin Ostrander, PhD, Megan D. Schollenberger, CRNP, Daniel C. Brennan, MD, Evan J. Lipson, MD

Get full text

Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation by Sami Alasfar, Isaac E. Hall, Sherry G. Mansour, Yaqi Jia, Heather R. Thiessen-Philbrook, Francis L. Weng, Pooja Singh, Bernd Schröppel, Thangamani Muthukumar, Sumit Mohan, Rubab F. Malik, Meera N. Harhay, Mona D. Doshi, Enver Akalin, Jonathan S. Bromberg, Daniel C. Brennan, Peter P. Reese, Chirag R. Parikh

Get full text

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics by Afrah S. Sait, MD, Teresa Po-Yu Chiang, MD, MPH, Kieren A. Marr, MD, MBA, Allan B. Massie, PhD, Willa Cochran, CRNP, Pali Shah, MD, Daniel C. Brennan, MD, Alvin G. Thomas, MS, Seema Mehta Steinke, MD, MS, Nitipong Permpalung, MD, MPH, Shmuel Shoham, MD, Christian Merlo, MD, Tania Jain, MD, Brian Boyarsky, MD, Olga Charnaya, MD, Ahmet Gurakar, MD, Kavita Sharma, MD, Christine M. Durand, MD, William A. Werbel, MD, Chiung-Yu Huang, PhD, Darin Ostrander, PhD, Niraj Desai, MD, Min Young Kim, MD, Sami Alasfar, MD, Evan M. Bloch, MD, PhD, Aaron A.R. Tobian, MD PhD, Jacqueline Garonzik-Wang, MD, PhD, Dorry L. Segev, MD, PhD, Robin K. Avery, MD

Get full text